Garda Capital Partners »

Biogen Idec shares owned by Garda Capital Partners

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Garda Capital Partners from 13F filings

Historical chart of Garda Capital Partners investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Garda Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Garda Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $456k 1.8k 258.77
2023-09-30 $205k 796 257.01
2023-03-31 $52k 186 278.03

More positions owned by Garda Capital Partners

Spdr S&p 500 Etf Tr Put Put Option
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Call Call Option
Microsoft Corp Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Call Call Option
Jpmorgan Chase & Co Put Put Option
Amazon Put Put Option
Invesco Qqq Tr Put Put Option
Invesco Qqq Tr Call Call Option
Spdr Dow Jones Indl Average Put Put Option
Spdr Dow Jones Indl Average Call Call Option

View all positions for Garda Capital Partners

Top funds holding Biogen Idec

PRIMECAP Management Company
Vanguard Group
Wellington Management Company
Jpmorgan Chase & Co
ClearBridge Advisors
Legal & General Group
T. Rowe Price Associates
Norges Bank Investment Management
Dimensional Fund Advisors
Van Eck Associates Corp.
Bank of New York Mellon
Amundi
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Ubs Global Asset Management Americas

View all funds holding Biogen Idec